Summary by Ground NewsElly Lilly & Co. sales are expected to compound at a 9% annually to $45 billion by 2027. The shares are up almost 20% year-to-date (YTD) on steadily increasing trading volumes. On April 28, the company announced its Q1 2022 earnings results, beating analysts' estimates.
2 months ago
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe
Time & Location
Sources are mostly out of (0)
No sources with tracked biases.
See less detail